UGA’s Voices from the Vanguard 2016 series concludes April 12 as Sarah J. Schlesinger tells how novel cells that were first spotted under a microscope in the 1970s have since been recognized as sentinels, sensors and “conductors of the immune symphony.”
That’s how the 2011 Nobel Prize committee described dendritic cells, which have enabled a wealth of insights into the development of drugs and vaccines, including those aimed at preventing AIDS.
Open free to the public, “Dendritic Cells, HIV Vaccines and the Nobel Prize: An Amazing Adventure,” will take place at 5:30 p.m. in the Chapel.
Schlesinger, an associate professor of clinical investigation at Rockefeller University, has worked with dendritic cells since she was a 17-year-old high school student. For this lecture, she will draw on more than 30 years of research and expertise in the use of dendritic cells to develop new therapies for diseases ranging from cancer to HIV.